RxDoctor Payments Data

Dale Brewer, DO

Family Medicine · Cedar Hill, MONPI 1952394041

Payments from drug & device makers

$1,414in general payments, 2019–2025

Across 95 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$783
  • Pfizer$129
  • Abbott$100
  • Axsome Therapeutics, Inc.$83
  • AstraZeneca$73
  • Novo Nordisk$43
  • plus $203 from 10 others

What the payments were for

  • Food & beverage$1,414100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,414 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$58,414
Medicare patients
171
Services billed
1,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban415$244,506
JardianceEmpagliflozin129$114,108
OzempicSemaglutide77$106,776
Trelegy ElliptaFluticasone/Umeclidin/Vilanter95$78,559
FarxigaDapagliflozin Propanediol47$59,178
MounjaroTirzepatide29$37,254
TrulicityDulaglutide25$32,824
XareltoRivaroxaban58$27,482
Risperdal ConstaRisperidone Microspheres20$26,843
XifaxanRifaximin16$25,555
Tresiba Flextouch U-100Insulin Degludec42$23,641
GemtesaVibegron34$22,516
Olanzapine25$22,120
JanuviaSitagliptin Phosphate34$20,306
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$18,706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$129$244,506415 claims
Novo NordiskOzempic$43$106,77677 claims
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$25$92,19879 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$73$85,78777 claims
Johnson & JohnsonXarelto, Risperdal Consta$17$54,32578 claims
Sumitomo Pharma America, Inc.Gemtesa$20$22,51634 claims
AbbVieLinzess$783$6,27111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cedar Hill

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →